Cresset Asset Management, LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1761013 Chicago, IL

Position in JAZZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,577,318

+$260,728 QoQ

Shares Held

13,633

+0.0% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 83.47392356781339.ToString("F0")% Shared 0.ToString("F0")% None 16.526076432186606.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cresset Asset Management, LLC holds $84,055,568 across 41 Biotechnology names. JAZZ ranks #4 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	739,191	$38,630,121
2	HALO	Halozyme Therapeutics, Inc.	259,397	$16,764,828
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,860	$3,509,804
4	JAZZ	Jazz Pharmaceuticals plc This page	13,633	$2,577,318
5	CPRX	Catalyst Pharmaceuticals, Inc.	86,063	$2,130,919
6	HRMY	Harmony Biosciences Holdings, Inc.	72,435	$2,028,904
7	REGN	Regeneron Pharmaceuticals, Inc.	2,537	$1,960,187
8	PVLA	Palvella Therapeutics, Inc.	11,860	$1,478,349

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,577,318	13,633	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$2,316,590	13,627	+0.4%	Shares	Sole	2026-02-17
2025-09-30	$1,788,394	13,569	+0.6%	Shares	Sole	2026-01-22
2025-06-30	$1,431,134	13,486	-7.2%	Shares	Sole	2026-01-22
2025-03-31	$1,804,644	14,536	-13.7%	Shares	Sole	2025-05-13
2024-12-31	$2,074,215	16,843	-49.6%	Shares	Sole	2025-02-14
2024-09-30	$3,726,552	33,449	+80.4%	Shares	Defined	2024-11-14
2024-06-30	$1,979,200	18,544	+11.4%	Shares	Defined	2024-08-14
2024-03-31	$2,005,112	16,651	+598.2%	Shares	Defined	2024-05-15
2023-12-31	$293,355	2,385	-37.7%	Shares	Defined	2024-02-14
2023-09-30	$495,884	3,831	+40.8%	Shares	Defined	2023-11-14
2023-06-30	$337,198	2,720	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.